期刊文献+

经尿道等离子汽化电切联合术后吡柔比星膀胱灌注治疗腺性膀胱炎 被引量:8

Plasmakinetic Superpulse Transurethral Resection Combined with Postoperative Pirarubicin Bladder Irrigation for Cystitis Glandularis
在线阅读 下载PDF
导出
摘要 目的探讨经尿道等离子汽化电切术联合术后吡柔比星膀胱灌注治疗腺性膀胱炎的临床疗效。方法对32例腺性膀胱炎患者在腰硬联合麻醉下行经尿道等离子汽化电切术;术后根据具体病情留置尿管5~7d,拔管前以化疗药物吡柔比星行膀胱灌注治疗,每周1次,共8次,后每月1次,连续10次。每3~6个月复查膀胱镜,观察膀胱黏膜情况,并选择性复查膀胱黏膜组织活检。结果 32例均手术成功,术中无严重出血和膀胱穿孔、水中毒等并发症发生,术后尿路刺激等症状均明显改善。术后随访4~36个月,23例治愈,6例好转,有效率90.6%;3例于术后6~10个月复发,复发者均再次行经尿道等离子汽化电切治疗。随访期间1例出现较严重的尿频、尿急、尿痛等膀胱刺激症,2例出现淡红色肉眼血尿,未发现恶变病例,无其他并发症。结论经尿道等离子汽化电切术联合术后吡柔比星膀胱灌注治疗具有安全、并发症少、疗效确切等优点,是治疗腺性膀胱炎的有效方法。 Objective To evaluate the clinical efficacy of plasmakinetic superpulse transurethral resection combined with postoperative pirarubicin bladder irrigation in cystitis glandularis. Meth- ods Thirty-two patients with cystitis glandularis underwent plasmakinetic superpulse transure- thral resection under combined spinal-epidural anesthesia. Postoperative indwelling catheters were used for 5-7 days. Before extubation, patients were given pirarubiein bladder irrigation 8 times once per week, followed by pirarubicin bladder irrigation 10 times once per month. In addi- tion, cystoscopy and biopsy were performed every 3-6 months to observe the bladder mucosa. Re- sults All operations were performed successfully without serious complications such as bleeding, bladder perforation and water intoxication. Furthermore, postoperative urinary irritation symp- toms were significantly improved. After follow-up for 4-36 months, 23 of the 32 patients were cured and 6 achieved improvement. The effective rate was 90. 6%. Three patients underwent plasmakinetic superpulse transurethral resection again due to the recurrence 6-10 months after op- eration. During the follow-up period, 1 patient had serious bladder irritation symptoms such as frequency, urgency and dysuria, and 2 patients had reddish gross hematuria. No malignant trans-formation and other complications were found. Conclusion Plasmakinetic thral resection combined with results in fewer complications postoperative pirarubicin bladder irrigation is in the treatment of cystitis glandularis. superpulse transure- safe and effective and results in fewer complications in the treatment of cystitis glandularis.
出处 《南昌大学学报(医学版)》 CAS 2013年第7期19-21,共3页 Journal of Nanchang University:Medical Sciences
关键词 腺性膀胱炎 经尿道等离子汽化电切术 吡柔比星 膀胱灌注 cystitis glandularis plasmakinetic superpulse transurethral resection pirarubicin bladder irrigation
  • 相关文献

参考文献8

  • 1Pantanowitz L, Otis C N. Cystitis glandularis[J]. Diagn Cyto pathol,2008,36(3) :181- 182.
  • 2G6mez dos Santos V G, Burgos Revilla F J, Garcia Gonzalez R. Glandular cystitis. Endovesical steroid treatment[J]. Arch Esp Urol,2000,53(5) :461-464.
  • 3Jost S P,Dixon J S,Gosling J A. Ultrastructural observations on cystitis cystic in human bladder urothelium[J]. Br J Urol, 1993,71(1) :23-33.
  • 4Rau A R,Kini H,Pai R R. Morphological evaluation of cystitis glandularis[J]. Indian J Pathol Microbiol, 2009,52 (2) : 203 -205.
  • 5Lanclin F,Anibjar M,Villette J M,et al. Telomerase activity as a potential marker in preneoplastic bladder lesions[J]. BJU Int,2000,85(4) :526- 531.
  • 6Black P C, Lange P H. Cystoprostatectomy and neobladder con- struction for florid cystitis glandularis[J]. J Urol, 2005,65 (1) : 174.
  • 7宋彦,宋永胜,吴斌.三种不同化疗药物膀胱灌注治疗腺性膀胱炎疗效对比[J].中国医学工程,2011,19(11):13-15. 被引量:12
  • 8肖振东,李长岭,马建辉,寿建忠,田军,王栋,毕新刚,鲁力.吡柔比星膀胱灌注预防膀胱癌术后复发的长期疗效观察[J].临床泌尿外科杂志,2009,24(4):271-273. 被引量:21

二级参考文献19

  • 1胡敬花.腺性膀胱炎的CT诊断及鉴别诊断[J].实用诊断与治疗杂志,2005,19(5):318-319. 被引量:2
  • 2吴天麟,张俊杰,王甫剑,韩从辉,梁清,姜波,邱祥政,贺厚光,王阔兴,范涛.吡柔比星膀胱内灌注防治浅表性膀胱癌术后复发(附109例报告)[J].东南大学学报(医学版),2006,25(2):113-115. 被引量:8
  • 3Okamura K, Ono Y, Kinukawa T, et al. Randomized study of single early instillation of (2″R)-4'-O-tetrahy- dropyranyl-doxorubicin for a single superficial bladder carcinoma[J]. Cancer, 2002, 94: 2363-2368.
  • 4Bohle A, Book P R. Intravesical bacille Calmette-Guerin versus mitomycin C in superficial bladder cancer: formal recta-analysis of comparative studies on tumor progression[J]. Urology, 2004, 63:682- 686.
  • 5Nakagawa S, Kojima M, Takada H, et al. Shortduration bladder instillation therapy with pirarubicin for superfi cial bladder tumor based on pharmacodynamic study [J]. Gan To Kagaku Ryoho, 1992, 19 (11): 1873 -- 1877.
  • 6川村繁美,藤岡知昭,久保隆他.表在性膀胱腄痬術後再發予防に对するPirarubicin(THP)膀胱注入療法の臨床的檢討[J].癌と臨床,1994,19(11):21-24.
  • 7Sylvester R J, van der Meijden A P, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from sevenEORTC trials[J]. Eur Urol, 2006, 49: 466-477.
  • 8Kanayama H, Yokota K, Kurokawa Y, etal. Postoperative prophylactic intravesical instillation of tetrahy- dropyranyl-adriamycin (THP) for superficial bladder cancer[J]. Gan To Kagaku Ryoho, 1999, 26: 651- 655.
  • 9Smith AK,Hansel DE,Jones JS.Role of cystitis cystical glandularisand intestinal metaplasia in development of bladder carcinoma[J].Urology,2008,71(5):915-918.
  • 10Rau AR,Kini H,Pai RR.Morphological evaluation of cystitis glan-dularis[J].Indian J Pathol Microbiol,2009,52(2):203-205.

共引文献31

同被引文献71

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部